CORDIS
EU research results

CORDIS

English EN
Induced pluripotent stem cell seeded active osteochondral nanofibrous scaffolds

Induced pluripotent stem cell seeded active osteochondral nanofibrous scaffolds

Objective

iP-OSTEO project focuses on development of novel cell-based scaffolds for bone and cartilage repair in patients with poor regenerative capacity. We are proposing technology combining iPSCs with improved regeneration capacity combined with nanostructured scaffolds based on electrospun scaffolds and drug delivery system stimulating cell regeneration based on electrosprayed and spray-dried particles. The system will deliver novel treatment method for older patients, for which the current cellular and cell-free methods are ineffective.

iP-OSTEO will reach its goals by creating an international and interdisciplinary training program. 7 companies (SMEs) and 7 academic institutions across European Union will join there forces though dedicated secondments. The activities will involve networking, research/training, workshop and dissemination secondments. The project has in total 239 secondments involving exchange of Early-stage and Experienced researchers. The consortium is bonded by Dr. Eva Filova – young scientist with experience in bone and cartilage tissue engineering.

The iP-OSTEO project will help in better integration of academic and industrial stakeholders across Europe and help diseased people by providing novel therapeutic methods. Nevertheless, project has 169 ESR secondment months leading to training of new generation of scientists with international connection and knowledge of intrasectorial enviroment.
Leaflet | Map data © OpenStreetMap contributors, Credit: EC-GISCO, © EuroGeographics for the administrative boundaries

Coordinator

USTAV EXPERIMENTALNI MEDICINY AKADEMIE VED CESKE REPUBLIKY VEREJNA VYZKUMNA INSTITUCE

Address

Videnska 1083
14220 Praha 4

Czechia

Activity type

Research Organisations

EU Contribution

€ 184 000

Participants (13)

Sort alphabetically

Sort by EU Contribution

Expand all

INOCURE SRO

Czechia

EU Contribution

€ 193 200

SZECHENYI ISTVAN UNIVERSITY

Hungary

EU Contribution

€ 165 600

OSPIN GMBH

Germany

EU Contribution

€ 82 800

BIONEER A/S

Denmark

EU Contribution

€ 9 200

ORTHOSERA GMBH

Austria

EU Contribution

€ 46 000

UNIVERSITY COLLEGE LONDON

United Kingdom

EU Contribution

€ 115 000

HOCHSCHULE RHEIN-WAAL-HSRW RHINE-WAAL UNIVERSITY OF APPLIED SCIENCES

Germany

EU Contribution

€ 55 200

LLS ROWIAK LASERLABSOLUTIONS GMBH

Germany

EU Contribution

€ 18 400

CORTICALIS AS

Norway

EU Contribution

€ 27 600

FRAUNHOFER GESELLSCHAFT ZUR FOERDERUNG DER ANGEWANDTEN FORSCHUNG E.V.

Germany

EU Contribution

€ 27 600

BIOFABICS LDA

Portugal

EU Contribution

€ 101 200

SCINUS CELL EXPANSION BV

Netherlands

EU Contribution

€ 32 200

INSTYTUT PODSTAWOWYCH PROBLEMOW TECHNIKI POLSKIEJ AKADEMII NAUK

Poland

EU Contribution

€ 41 400

Project information

Grant agreement ID: 824007

Status

Ongoing project

  • Start date

    1 February 2019

  • End date

    31 January 2023

Funded under:

H2020-EU.1.3.3.

  • Overall budget:

    € 1 099 400

  • EU contribution

    € 1 099 400

Coordinated by:

USTAV EXPERIMENTALNI MEDICINY AKADEMIE VED CESKE REPUBLIKY VEREJNA VYZKUMNA INSTITUCE

Czechia